HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Diabetes Mellitus

A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Networked: 33372 relevant articles (895 outcomes, 3417 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hypertension (High Blood Pressure)
2. Obesity
3. Dyslipidemias (Dyslipidemia)
4. Heart Failure
5. Hyperglycemia

Experts

1. Stone, Gregg W: 35 articles (12/2015 - 01/2002)
2. Angiolillo, Dominick J: 27 articles (12/2015 - 07/2006)
3. Hofman, Albert: 26 articles (01/2016 - 02/2003)
4. Mehran, Roxana: 25 articles (10/2015 - 01/2002)
5. Stefanadis, Christodoulos: 24 articles (03/2015 - 12/2002)
6. Lip, Gregory Y H: 23 articles (10/2015 - 08/2003)
7. Aronow, Wilbert S: 23 articles (11/2010 - 01/2002)
8. Adeghate, Ernest: 21 articles (11/2014 - 01/2004)
9. Levy, Andrew P: 20 articles (01/2015 - 12/2006)
10. Ogawa, Hisao: 20 articles (01/2015 - 05/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Diabetes Mellitus:
1. Insulin (Novolin)FDA Link
2. Glucose (Dextrose)FDA LinkGeneric
3. Blood Glucose (Blood Sugar)IBA
4. Streptozocin (Streptozotocin)FDA Link
5. CholesterolIBA
6. Carbon MonoxideIBA
7. Hemoglobins (Hemoglobin)IBA
01/01/1983 - "According to our experience, Hemoglobin A1 is a very useful marker to ensure the diagnosis of diabetes mellitus post mortem. "
10/01/2015 - "Through the survey of patients' compliance with treatment, it was confirmed that telemedicine services increased patients' compliance with drug administration, facilitated improvement of lifestyle habits, improved glycated hemoglobin for patients with diabetes mellitus, and enhanced the rate of blood pressure control. "
09/01/2015 - "The intervention had no short-term effect on secondary outcomes of hemoglobin A1c levels, depression, or the Risk Perceptions and Risk Knowledge Survey of Diabetes Mellitus or National Eye Institute Vision Function Questionnaire 25 composite scores; however, both groups had improved adherence to diabetes mellitus self-care behaviors from baseline to 6-month follow-up. "
10/01/2015 - "OBJECTIVETo verify the influence of quality of life in treatment adherence of patients with diabetes mellitus.METHODSystematic review of the literature using the databases MEDLINE, CINAHL, Scopus, LILACS, SciELO and Web of Science with studies published between 2003 and 2014 in English, Portuguese or Spanish.RESULTSSix studies were included in the review, three were identified as having better quality of life scores, being related to better adherence to diabetes treatment measured by glycated hemoglobin or characteristics related to diet, exercise, use of medication and foot care. "
01/01/2015 - "Hemoglobin A1c (HbA1c) is now considered to be the marker of choice in diagnosis and management of diabetes mellitus, based on the results of certain landmark clinical trials. "
8. Metformin (Glucophage)FDA LinkGeneric
9. Lipoproteins (Lipoprotein)IBA
10. CreatinineIBA

Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Transplants (Transplant)
3. Stents
4. Kidney Transplantation
5. Gastric Bypass (Roux-en-Y Gastric Bypass)